Minimally Invasive and Non Invasive Surgery Market (2009 - 2014)

Table of Contents

1. INTRODUCTION

• 1.1. KEY TAKE AWAYS
• 1.2. MARKETS COVERED
• 1.3. STAKEHOLDERS
  • 1.3.1. MINIMALLY/NON-INVASIVE SURGICAL EQUIPMENT MANUFACTURING COMPANIES
  • 1.3.2. HOSPITAL SURGICAL DEPARTMENTS AND INDIVIDUAL SURGEONS
  • 1.3.3. OUTPATIENT SURGERY CENTERS
  • 1.3.4. BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS

2. SUMMARY

3. MARKET OVERVIEW

• 3.1. EVOLUTION OF THE MINIMALLY INVASIVE SURGERY MARKET
  • 3.1.1. MINIMALLY INVASIVE SURGERY VS CONVENTIONAL OPEN SURGERY
• 3.2. THE FUTURE OF MINIMALLY INVASIVE SURGERY
• 3.3. DEFINING THE MINIMALLY INVASIVE SURGERY MARKET
• 3.4. DEFINING THE MINIMALLY INVASIVE PRODUCT MARKET
• 3.5. DEFINING THE MINIMALLY INVASIVE APPLICATION MARKET
• 3.6. DEFINING THE MINIMALLY INVASIVE TECHNOLOGY MARKET
• 3.7. DEFINING THE MINIMALLY INVASIVE END-USER MARKET
• 3.8. MARKET DRIVERS FOR MINIMALLY INVASIVE SURGERY MARKET
  • 3.8.1. INCREASE IN AGING POPULATION BOOSTS THE DEMAND FOR SURGERIES
  • 3.8.2. INCREASE IN AWARENESS AND DEMAND FOR PATIENT-FRIENDLY OPERATING METHODS
  • 3.8.3. MINIMALLY INVASIVE SURGERY HELPS REDUCE HEALTHCARE COST
• 3.9. RESTRAINTS FOR THE MINIMALLY INVASIVE SURGERY MARKET
• 3.10.OPPORTUNITIES IN THE MINIMALLY INVASIVE SURGERY MARKET
  • 3.10.1. HUGE MARKET SIZE ATTRACTING NEW ENTRANTS IN MINIMALLY INVASIVE MARKET
  • 3.10.2. PHYSICIANS ARE SETTING A STRONG FOUNDATION FOR THE FUTURE OF MINIMALLY INVASIVE SURGERY MARKET

4. MINIMALLY INVASIVE PRODUCT MARKET

• 4.1. SURGICAL DEVICES
  • 4.1.1. MARKET DRIVERS
    • 4.1.1.1. INNOVATIVE MARKETING MODEL BOOSTING THE DEMAND FOR MIS INSTRUMENTS
    • 4.1.1.2. INCREASING NUMBER OF MIS PROCEDURES IS BOOSTING THE DEMAND FOR MIS INSTRUMENTS
  • 4.1.2. HAND INSTRUMENTS
  • 4.1.3. FORCEPS/GRASPERS/DISSECTORS
  • 4.1.4. SCISSORS
  • 4.1.5. INSUFFLATORS
    • 4.1.5.1. DEVELOPMENTS
  • 4.1.6. POWER SURGICAL INSTRUMENTS
  • 4.1.7. OTHER SURGICAL DEVICES
• 4.2. MONITORING AND VISUALIZATION SYSTEMS
  • 4.2.1. MARKET DRIVERS
  • 4.2.2. CAMERAS AND VIDEO SUPPORT
  • 4.2.3. OTHER MONITORING AND VISUALIZATION MARKET
• 4.3. ELECTROSURGICAL AND AUXILIARY EQUIPMENT
  • 4.3.1. LASERS
    • 4.3.1.1. DRIVERS
  • 4.3.2. OTHER MARKET
• 4.4. ENDOSURGICAL EQUIPMENT
  • 4.4.1. MARKET DRIVERS
  • 4.4.2. ENDOSCOPES AND OTHER ENDOSURGICAL EQUIPMENT
• 4.5. MEDICAL ROBOTICS
  • 4.5.1. MARKET DRIVERS
    • 4.5.1.1. IMPROVED SURGICAL RESULTS ATTRACTING MORE PATIENTS
    • 4.5.1.2. MEDICAL ROBOTICS INCREASE HOSPITAL REVENUE
  • 4.5.2. SURGICAL NAVIGATION SYSTEMS
  • 4.5.3. SURGICAL ROBOTS
    • 4.5.3.1. DRIVERS
  • 4.5.4. DIGITAL OPERATING ROOMS
  • 4.5.5. OTHERS

5. MINIMALLY INVASIVE SURGERY MARKET BY APPLICATION

• 5.1. COSMETIC SURGERY
  • 5.1.1. DRIVERS
  • 5.1.2. PLASTIC SURGERY
  • 5.1.3. BREAST SURGERY
  • 5.1.4. OBESITY SURGERY
    • 5.1.4.1. DRIVERS
      • 5.1.4.1.1. INCREASING INCIDENCE OF OBESITY IS DRIVING THE BARIATRIC SURGERY MARKET
      • 5.1.4.1.2. INCREASE IN AWARENESS OF OBESITY AS A DANGEROUS DISEASE
  • 5.1.5. HAIR REMOVAL
    • 5.1.5.1. DRIVERS AND RESTRAINTS
• 5.2. GASTROINTESTINAL SURGERY
  • 5.2.1. MARKET DRIVERS
• 5.3. GYNECOLOGICAL SURGERY
  • 5.3.1. HYSTERECTOMIES
• 5.4. UROLOGICAL SURGERY
• 5.5. THORACIC SURGERY
• 5.6. CARDIAC SURGERY
  • 5.6.1. DRIVERS
    • 5.6.1.1. TECHNOLOGY DEVELOPMENTS ARE BOOSTING THE CARDIAC SURGERY MARKET
    • 5.6.1.2. NEW AND IMPROVED SURGICAL PROCEDURES DRIVING THE MARKET GROWTH FOR CARDIAC SURGERY
  • 5.6.2. ROBOT-ASSISTED CARDIAC SURGERY
• 5.7. VASCULAR SURGERY
• 5.8. ORTHOPEDIC SURGERY
  • 5.8.1. JOINT REPLACEMENT
  • 5.8.2. SPINAL SURGERY
  • 5.8.3. OTHER SURGERIES

6. MINIMALLY INVASIVE SURGERY MARKET-BY TECHNOLOGY

• 6.1. NON-VISUAL IMAGING
  • 6.1.1. OPTICAL IMAGING
    • 6.1.1.1. Market Drivers
  • 6.1.2. NON-OPTICAL IMAGING
  • 6.1.3. HYBRID IMAGING
• 6.2. MEDICAL ROBOTICS
  • 6.2.1. MARKET DRIVERS
    • 6.2.1.1. Improved Surgical Results Attracting Patients
    • 6.2.1.2. Cost effectiveness Attracting Medical Facilities
• 6.3. TRANSCATHETER SURGERY
  • 6.3.1. PERCUTANEOUS ABLATION
  • 6.3.2. RADIOFREQUENCY ABLATION
    • 6.3.2.1. Market Drivers
      • 6.3.2.1.1. Increasing Consumer Base Driving the Market Growth for RFA
      • 6.3.2.1.2. RFA Gives More Effective Results for Treatment of Liver Tumor
      • 6.3.2.1.3. Most Promising Nonsurgical Ablation for Breast Cancer Treatment
    • 6.3.2.2. Restraints
    • 6.3.2.3. Developments
  • 6.3.3. MICROWAVE ABLATION
    • 6.3.3.1. Market Drivers
      • 6.3.3.1.1. Microwave Ablation Takes Lesser Time for Operating Tumors
      • 6.3.3.1.2. Microwave Ablation Involves Faster Generation of Heat
• 6.4. LAPAROSCOPIC SURGERY

7. MINIMALLY INVASIVE SURGERY MARKET BY END-USERS

• 7.1. HOSPITAL SURGICAL DEPARTMENTS
  • 7.1.1. MARKET DRIVERS
• 7.2. OUTPATIENTS SURGERY CENTER
  • 7.2.1. MARKET DRIVERS
• 7.3. GROUP PRACTICES
• 7.4. INDIVIDUAL SURGEONS
• 7.5. MEDICAL SCHOOLS
• 7.6. OTHER USERS

8. MINIMALLY INVASIVE SURGERY PATENT ANALYSIS

9. MINIMALLY INVASIVE SURGERY MARKET COMPANY PROFILES

• 9.1. ABBOTT LABORATORIES
  • 9.1.1. OVERVIEW
  • 9.1.2. STRATEGIES AND DEVELOPMENTS
• 9.2. AESCULAP (A SUBSIDIARY OF B. BRAUN)
  • 9.2.1. OVERVIEW
  • 9.2.2. STRATEGIES AND DEVELOPMENTS
• 9.3. ARTHROCARE CORP.
  • 9.3.1. OVERVIEW
  • 9.3.2. STRATEGY AND DEVELOPMENTS
• 9.4. BIOMET, INC.
  • 9.4.1. OVERVIEW
  • 9.4.2. DEVELOPMENTS
• 9.5. DEPUY SPINE
  • 9.5.1. OVERVIEW
  • 9.5.2. STRATEGIES AND DEVELOPMENTS
• 9.6. DISC-O-TECH MEDICAL TECHNOLOGIES LTD
  • 9.6.1. OVERVIEW
• 9.7. ALPHATEC SPINE
  • 9.7.1. OVERVIEW
  • 9.7.2. STRATEGIES AND DEVELOPMENTS
• 9.8. GIVEN IMAGING
  • 9.8.1. OVERVIEW
  • 9.8.2. STRATEGIES AND DEVELOPMENTS
• 9.9. HANSEN MEDICAL
  • 9.9.1. OVERVIEW
  • 9.9.2. STRATEGIES AND DEVELOPMENTS
• 9.10.INTEGRA LIFESCIENCES
  • 9.10.1.OVERVIEW
  • 9.10.2.STRATEGIES AND DEVELOPMENTS
• 9.11.MENTICE MEDICAL SIMULATION
  • 9.11.1.OVERVIEW
  • 9.11.2.STRATEGY
• 9.12.NUVASIVE INC.
  • 9.12.1.OVERVIEW
  • 9.12.2.DEVELOPMENTS
• 9.13.OLYMPUS CORPORATION
  • 9.13.1.OVERVIEW
  • 9.13.2.STRATEGIES AND DEVELOPMENTS
• 9.14.SMITH & NEPHEW
  • 9.14.1.OVERVIEW
  • 9.14.2.STRATEGIES AND DEVELOPMENTS
• 9.15.STRYKER CORPORATION
  • 9.15.1.OVERVIEW
  • 9.15.2.STRATEGIES AND DEVELOPMENTS
• 9.16.SYNTHES, INC.
  • 9.16.1.OVERVIEW
  • 9.16.2.STRATEGY
• 9.17.TELEFLEX
  • 9.17.1.OVERVIEW
  • 9.17.2.STRATEGIES AND DEVELOPMENTS
• 9.18.COVIDIEN LTD
  • 9.18.1.OVERVIEW
  • 9.18.2.STRATEGIES AND DEVELOPMENTS
• 9.19.UNITED STATES SURGICAL CORP. (A SUBSIDIARY OF COVIDIAN)
  • 9.19.1.OVERVIEW
• 9.20.ZIMMER HOLDINGS INC.
  • 9.20.1.OVERVIEW
  • 9.20.2. STRATEGIES
• 9.21.MEDTRONIC SOFAMOR DANEK
  • 9.21.1.OVERVIEW
  • 9.21.2.STRATEGIES
• 9.22.PENTAX MEDICAL COMPANY
  • 9.22.1.OVERVIEW
  • 9.22.2.STRATEGIES AND DEVELOPMENTS
• 9.23.SURGICAL INNOVATIONS GROUP PLC.
  • 9.23.1.OVERVIEW
  • 9.23.2.DEVELOPMENTS
• 9.24.K2M INC
  • 9.24.1.OVERVIEW
  • 9.24.2.DEVELOPMENTS
• 9.25.BOSTON SCIENTIFIC CORPORATION
  • 9.25.1.OVERVIEW
  • 9.25.2.STRATEGIES AND DEVELOPMENTS
  • 9.25.3. DEVELOPMENTS
• 9.26.CHARLES RUSSELL BARD INC.
  • 9.26.1.OVERVIEW
  • 9.26.2.STRATEGIES AND DEVELOPMENTS
• 9.27.FUJIFILM CORPORATION
  • 9.27.1.OVERVIEW
  • 9.27.2.STRATEGIES AND DEVELOPMENTS
• 9.28.KARL STORZ ENDOSKOPE BERLIN GMBH & CO
  • 9.28.1.OVERVIEW
  • 9.28.2.STRATEGY
• 9.29.GYRUS ACMI CORP.
  • 9.29.1.OVERVIEW
• 9.30.COOPER SURGICAL INC.
  • 9.30.1.OVERVIEW
  • 9.30.2.STRATEGIES AND DEVELOPMENTS
• 9.31.CLARUS MEDICAL LLC
  • 9.31.1.OVERVIEW
  • 9.31.2.STRATEGIES
• 9.32.ETHICON ENDO-SURGERY, INC.
  • 9.32.1.OVERVIEW
  • 9.32.2.STRATEGY
• 9.33.VALLEYLAB
  • 9.33.1.OVERVIEW
  • 9.33.2.STRATEGIES
• 9.34.JOHNSON & JOHNSON INC.
  • 9.34.1.OVERVIEW
  • 9.34.2.DEVELOPMENTS
• 9.35.CONMED CORPORATION
  • 9.35.1.OVERVIEW
  • 9.35.2.DEVELOPMENTS
• 9.36.INTUITIVE SURGICAL INC
  • 9.36.1.OVERVIEW

APPENDIX

U.S. PATENTS